PharmAbcine Inc. Logo

PharmAbcine Inc.

Develops antibody therapies for cancer, eye diseases, and vascular-related disorders.

208340 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
대전광역시 유성구 유성대로1689번길 70 KT대덕2연구센터 연구2동 2층, 대전광역시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

PharmAbcine Inc. is a clinical-stage biotechnology company founded in 2008, specializing in the development of novel antibody therapeutics. The company leverages its proprietary fully human antibody library and discovery platforms to create next-generation, IgG-based monoclonal antibody (mAb) candidates. Its development pipeline focuses on treatments for cancer, neovascular eye diseases, and other vascular-related disorders. PharmAbcine's business model centers on advancing its therapeutic candidates through clinical trials with the objective of licensing them out to global partners.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for PharmAbcine Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-16 00:00
Delisting Announcement
[기재정정]기타경영사항(자율공시) (상장폐지결정효력정지 가처분 신청)
Korean 12.1 KB
2025-08-19 00:00
Regulatory News Service
투자판단관련주요경영사항 (PMC-309 독점실시권 라이선스 계약(기술이전 계약))
Korean 10.0 KB
2025-08-19 00:00
Legal Proceedings Report
소송등의제기ㆍ신청(자율공시:일정금액미만의청구) (위약벌청구의 소)
Korean 8.7 KB
2025-08-14 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 1.8 MB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.5 MB

Automate Your Workflow. Get a real-time feed of all PharmAbcine Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for PharmAbcine Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Klaria Pharma Holding AB Logo
Develops oral films for non-invasive drug delivery as an alternative to injections and sprays.
Sweden KLAR
KOA SHOJI HOLDINGS CO.,LTD. Logo
Imports APIs and manufactures generic drugs for Japan's pharmaceutical industry.
Japan 9273
KOBAYASHI PHARMACEUTICAL  CO.,LTD. Logo
Manufactures OTC pharma, personal care, and household goods for niche consumer markets.
Japan 4967
Kohjin Bio Co., Ltd. Logo
A CDMO providing culture media & bioservices for cell therapy, research, and diagnostics.
Japan 177A
KOLON LIFE SCIENCE Inc. Logo
Develops gene therapies and manufactures APIs, providing global CDMO/CMO services.
South Korea 102940
Kolon TissueGene, Inc. Logo
Developing cell and gene therapies for orthopedic and degenerative disorders.
United States of America 950160
Develops animal health products and novel drugs for human cancer and autoimmune diseases.
South Korea 041960
KOREA ARLICO PHARM CO.,LTD. Logo
Manufactures generic drugs and provides CDMO services to a global market.
South Korea 260660
Develops and manufactures prescription (ETC) and over-the-counter (OTC) medicines for public health.
South Korea 014570
K Pharma,Inc. Logo
Develops iPS cell-based drugs and regenerative medicine for central nervous system disorders.
Japan 4896

Talk to a Data Expert

Have a question? We'll get back to you promptly.